We have Vaccine for COVID-19! What to Recommend for Pregnant Women? - Revista Brasileira de Ginecologia e Obstetrícia
Revista Brasileira de Ginecologia e Obstetrícia. 2021;43(2):81-83
On January 17, 2021, two vaccines were approved by ANVISA for emergency use to help combat COVID-19: Coronavac and Covishield/Oxford. The first vaccine is composed of inactivated (killed) viruses, was produced by the Chinese company Sinovac and in Brazil, will be produced by the Butantã Institute (São Paulo). The second is an adenovirus non-replicating viral vector vaccine and was produced by the pharmaceutical company Serum Institute of India in partnership with AstraZeneca/Oxford University. In Brazil, it will be produced by the Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro.
In view of the worrying and prolonged scenario of the COVID-19 pandemic, it is essential that Brazilian scientific societies share scientific knowledge free of political ideologies with their peers and position themselves based on the available evidence in relation to vaccines against COVID-19. In this context, gynecologists and obstetricians have requested guidelines on the indication of these vaccines in pregnant, puerperal and nursing women. I will highlight some points I consider important to support my opinion with which I will conclude this editorial.
[…]
Search
Search in:
Search
Search in:
On January 17, 2021, two vaccines were approved by ANVISA for emergency use to help combat COVID-19: Coronavac and Covishield/Oxford. The first vaccine is composed of inactivated (killed) viruses, was produced by the Chinese company Sinovac and in Brazil, will be produced by the Butantã Institute (São Paulo). The second is an adenovirus non-replicating viral vector vaccine and was produced by the pharmaceutical company Serum Institute of India in partnership with AstraZeneca/Oxford University. In Brazil, it will be produced by the Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro.
In view of the worrying and prolonged scenario of the COVID-19 pandemic, it is essential that Brazilian scientific societies share scientific knowledge free of political ideologies with their peers and position themselves based on the available evidence in relation to vaccines against COVID-19. In this context, gynecologists and obstetricians have requested guidelines on the indication of these vaccines in pregnant, puerperal and nursing women. I will highlight some points I consider important to support my opinion with which I will conclude this editorial.
[...]
Comments